Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
Investment research built around change detection.
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
Robinhood Markets shares rallied 14.10% to $108.51 on strong investor sentiment across crypto-linked equities, driven by a broader Bitcoin and cryptocurrency market rally plus regulatory optimism around digital asset frameworks like the CLARITY Act, according to market analysis. The gain builds on positive momentum from recent strong financial quarters and robust user asset growth.
Robinhood shares rallied 6.07% to $100.87 on regulatory tailwinds and post-earnings momentum. Per Yahoo Finance, investor sentiment strengthened following President Trump's push for clearer U.S. cryptocurrency rules—a material catalyst for a platform with significant crypto engagement. The move also builds on Q2 2026 results (revenue +32% YoY to $1.3B, EPS $0.62) and ongoing expansion into prediction markets and international markets via UK FCA authorization.
HOOD earnings release scheduled for 2026-11-04; monitor Bitcoin price action and any legislative updates on the CLARITY Act or Trump administration digital asset policy.
What changed: Circle Internet Group surged 6.00% to $88.68 following a landmark acquisition of IBM's global blockchain patent portfolio—nearly 1,000 issued patents and over 680 patent families—combined with favorable U.S. Senate regulatory clarity that explicitly shields private stablecoin issuers from tightened restrictions on government-sponsored digital tokens, per investing.com and finance.yahoo.com. The broader crypto market rally provided additional tailwind.
Detected Aug 21, 11:30 AM ET
Changes History →Circle earnings scheduled for 2026-11-11 (consensus EPS estimate $0.29); monitor for further Senate regulatory action and competitive patent-licensing developments in the blockchain sector.
What changed: Freeport-McMoRan rose 4.63% to $74.52, driven by strength in the global copper market amid a persistent supply squeeze and elevated demand from AI data centers, electric vehicles, and grid electrification, according to market commentary. Investor sentiment also benefited from recent quarterly earnings beats and positive recovery updates for the Grasberg minerals district. The broader mineral and metals sectors are experiencing renewed momentum.
Detected Aug 21, 11:30 AM ET
Changes History →FCX earnings scheduled for 2026-10-22 (consensus EPS estimate $0.72); monitor copper prices and physical supply indicators for signals of demand or margin sustainability.
What changed: SoFi Technologies rose 5.81% to $18.96, extending gains from recent positive momentum. Piper Sandler initiated coverage with an Overweight rating and $22 price target, citing strength in the company's personal finance growth model. This follows strong Q2 results reported last quarter—$1.2 billion in adjusted net revenue (+40% YoY) and record loan originations of $14.8 billion—which continue to underpin bullish investor sentiment.
Detected Aug 21, 11:30 AM ET
Changes History →SoFi earnings scheduled for 2026-10-27 (consensus EPS estimate $0.16); watch for loan origination trends and adjusted net revenue growth relative to Q2's 40% YoY pace.
What changed: HCA Healthcare rose 3.64% to $421.07 following disclosure of institutional accumulation in recent SEC Form 13F filings released August 21, with major asset managers including Tocqueville Asset Management, Silvant Capital Management, and NewEdge Wealth taking or growing positions. MarketBeat consensus rating of 'Moderate Buy' with an average price target of $462.64 underscores a valuation gap above current trading levels, supported by Q2 fundamentals showing 8.7% year-over-year revenue growth to $20.23 billion.
Detected Aug 21, 11:30 AM ET
Source: investor.hcahealthcare.com ↗
Changes History →HCA earnings on October 23, 2026 (consensus EPS estimate $6.78); monitor whether institutional accumulation sustains or reverses if uninsured patient volumes or payer mix headwinds worsen.
What changed: Albemarle (ALB) rose 4.69% to $140.49, driven by sustained investor optimism following the company's strong second-quarter earnings report, which featured an adjusted EPS beat of $3.75 versus consensus estimates and a tripling of energy storage segment EBITDA on higher lithium prices. Management also raised segment guidance and trimmed capital expenditure plans, prompting analyst re-ratings with higher price targets.
Detected Aug 21, 11:30 AM ET
Changes History →Earnings scheduled for November 4, 2026 (consensus EPS estimate $3.33); monitor lithium spot prices and any updates to capital allocation strategy.
What changed: IonQ rose 6.36% to $44.17, extending gains from its stellar Q2 earnings report released earlier this month. According to Yahoo Finance, the company reported $80.05M in revenue (+286.7% YoY) and raised full-year 2026 guidance to $280–$290M; the move also reflects ongoing institutional buying disclosures and high-profile company representation at industry events like Quantum Week. Volume of 8.2M shares runs 1.31x the historical average for this point in the session.
Detected Aug 21, 11:30 AM ET
Changes History →IonQ earnings scheduled for November 4, 2026 (consensus: −$0.18 EPS); monitor for any updates on SkyWater Technology partnerships and institutional positioning changes in SEC filings.
What changed: Marvell Technology fell 5.21% to $237.93 despite a positive custom silicon and warrant deal with Google, driven by profit-taking after a rapid run-up, elevated valuation concerns (trading at over 80x forward earnings per Yahoo Finance), and pre-earnings positioning ahead of the August 27 earnings report. Volume traded 8.1M shares at 2.28x the historical average for this time of day, indicating elevated selling pressure.
Detected Aug 21, 11:30 AM ET
Changes History →Marvell's Q2 2026 earnings release on August 27; consensus EPS estimate is $0.93. Monitor whether management guidance allays or reinforces valuation and dilution concerns.
What changed: Merck gained 2.18% to $152.50 following positive Phase 3 clinical trial results for its personalized mRNA cancer vaccine developed with Moderna, combined with Keytruda, which met primary efficacy goals for recurrence-free survival in high-risk patients. Goldman Sachs and other major institutions subsequently raised price targets on the stock, driving investor enthusiasm in oncology-focused equities.
Detected Aug 21, 11:30 AM ET
Changes History →MRK earnings on 2026-10-29 (consensus EPS estimate: $2.27); regulatory pathway and timeline for the mRNA cancer vaccine combination therapy approval.
What changed: Accenture rebounded +3.29% to $187.32, driven by renewed investor confidence in the company's AI-driven services positioning and value-oriented buying at depressed valuations (web catalyst). The stock has gained 26.7% over the past month as market participants reassess ACN's long-term traction in enterprise artificial intelligence and cloud modernization, reversing earlier oversold conditions. Volume of 1.56M shares runs 0.78x historical average, typical for early-session trading.
Detected Aug 21, 11:30 AM ET
Changes History →Accenture earnings on 2026-09-24 (consensus EPS estimate $3.19); monitor whether AI-driven service demand and capital return programs support forward guidance.
What changed: Target's stock rose 2.87% to $162.79, continuing momentum from its Q2 fiscal 2026 earnings beat and raised full-year guidance. The company reported net sales of $26.5 billion (up 5.3%) with comparable sales up 3.8%, adjusted EPS doubled year-over-year (aided by a $994 million tariff refund), and management raised its full-year outlook. Guggenheim raised its price target to $175 from $150, and Argus to $180 from $150.
Detected Aug 21, 11:30 AM ET
Changes History →Monitor Target's next earnings update and track execution on store/digital transformation initiatives; watch for any tariff policy changes that could affect future refund expectations.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

Tesla (TSLA) Stock Jumps as Nevada Approves Up to 5,000 Robotaxis, Feeding the Autonomy Premium
Tesla rose about 4.5% to roughly $360 on August 21 (as much as ~5.5% intraday) after the Nevada Transportation Authority unanimously cleared it to operate up to 5,000 paid robotaxis in the Las Vegas area — up from a 10-vehicle cap days earlier. It matters because Tesla is priced as an autonomy platform, not a carmaker: net income is down ~35% year over year on a ~4% trailing operating margin, yet the stock trades near 358x trailing and 181x forward earnings. The same approval moved Uber under 2% (cleared for 1,000) and was immaterial to Alphabet's Waymo — the size of Tesla's reaction is the autonomy premium in action. Wall Street is split like almost no other mega-cap: an average target near $395 but a range from about $25 (GLJ's Gordon Johnson, Sell) to $600 (the Street high). It is a permit, not paid rides — one catalyst among several, and a real step forward with a long way still to travel.

Coinbase (COIN) Stock Jumps ~7%: A Bitcoin Rebound, Treasury Buybacks, and the CLARITY Act
Coinbase jumped about 7% to roughly $171 on August 20 — part of a ~17% two-day surge — as several forces pulled together: a genuine Bitcoin rebound (up ~3.5% to ~$71,500), a U.S. Treasury buyback move that eased yields, short-covering, and a White House crypto event where President Trump pushed the CLARITY Act — a tailwind uniquely relevant to the largest U.S. exchange. The high-beta crypto stocks outran the coin (COIN ~+7%, MSTR high-single digits vs Bitcoin ~+3.5%), magnifying the bounce. It landed on a beaten-down, loss-making stock (down ~43% over 52 weeks, a $359M Q2 loss), so the snap-back was sharp. Wall Street stays net-bullish (Buy consensus, ~$196 target), but targets have been falling and the move rests partly on a crypto rebound and a bill that still faces a mid-September Senate vote.

Deere (DE) Stock Jumps ~9%: A Q3 Beat, a Called Ag-Cycle Bottom, and a Data-Center Construction Tailwind
Deere jumped about 9% to roughly $634 on August 20 after fiscal Q3 earnings of $5.10 a share beat the ~$4.70 consensus and it raised the low end of its full-year net-income guidance to $4.75–$5.0 billion — but the real catalysts were underneath: CEO John May called 2026 the bottom of the multi-year farm-equipment downcycle, and the Construction & Forestry segment surged (net sales +18%, operating margin up to 12.1% from 7.7%) on higher volumes and strong infrastructure, data-center and energy demand. It was the mirror image of Walmart, which beat on EPS but missed on comps and fell ~9% the same day — Deere surprised a skeptical, Hold-heavy Street, while Walmart disappointed a bulled-up one. After a ~30% run in 2026 to near its high, the rally left the stock within about 2% of the ~$645 consensus target, at ~28× next-year and ~35× trailing earnings still below year-ago levels — leaving the fiscal-2027 order book as the swing factor.

Walmart (WMT) Stock Falls ~9%: A Beat-and-Raise, Slowing Comps, and Tariff-Boosted Profit
Walmart fell about 9% to roughly $104 on August 20 despite beating on earnings ($0.81 vs $0.74) and revenue and raising its full-year sales outlook — a classic 'beat-and-raise the market sold.' Three things drove it: U.S. comparable sales grew just 2.6% (the slowest in roughly six years and below the ~3.8% consensus), the profit beat got a one-time boost from a ~$2.9 billion tariff refund (though underlying operating profit still grew near the top of guidance), and Walmart guided third-quarter EPS lower ($0.62–$0.64) as it reinvests the windfall into lower prices. Against a demanding mid-30s forward multiple on a ~3%-net-margin retailer, that mix was too much — even as the broad market was barely changed on the day. It is also the market's clearest read that the U.S. consumer is cooling.

Newmont (NEM) Stock Jumps ~7%: A Gold Surge, a $6B Buyback, and the Barrick Settlement
Newmont was up about 7% intraday, to roughly $124, on August 19 as gold surged toward ~$4,500 an ounce (after a U.S. Treasury move to buy back longer-dated debt lowered yields and the dollar) and the whole mining group rallied — the same group had already jumped ~20% in an August 3–7 breakout week. Newmont carries two extra layers: record free cash flow (~$9.7B trailing, a 55% operating margin, a net-cash balance sheet and a new $6B buyback), and a just-settled multi-year Barrick dispute over Nevada Gold Mines — Newmont agreed to pay $1.95B to fold in prime deposits, and the initial reaction favored it as Barrick fell ~6%. The paradox: after an ~80% one-year run, NEM still trades at only ~11.5× forward earnings, reflecting the market's assumption that high gold won't last. Analyst targets from $67 to $170 are really a bet on the gold price.

Dell (DELL) Stock Falls More Than 6%: The AI-Server Boom Meets a Memory-Cost Squeeze
Dell fell about 6–7% to roughly $440 on August 19 — not on any demand warning (analysts actually raised targets that day), but as AI-hardware names lagged a firm market and investors refocused on a known worry: rising DRAM/NAND memory and HDD storage costs squeezing the already-thin margins on its booming AI servers, ahead of the September 1 earnings. It is the uncomfortable other side of the storage/memory super-cycle: soaring prices lift the makers (Micron and SanDisk in memory, Western Digital in hard drives) but raise input costs for system assemblers like Dell. After a ~218% one-year run and a re-rating to ~24× forward earnings on a ~19%-gross-margin business, the September print — where the AI-server margin line will show whether the squeeze is temporary or structural — is the key test. Analyst targets run from $360 to $700.











